Leptin receptor isoform expression in rat osteoblasts and their functional analysis  by Lee, Yun-Jung et al.
Leptin receptor isoform expression in rat osteoblasts
and their functional analysis
Yun-Jung Leea, Jung-Hyun Parkb, Sung-Kyu Juc, Kwan-Hee Youc, Jea Seung Koa,
Hyun-Man Kima;
aLaboratory for the Study of Molecular Biointerface, Department of Oral Anatomy, College of Dentistry and Intellectual Biointerface Engineering
Center (IBEC), BK21 HLS, Seoul National University, Yeonkun-Dong, Chongro-Ku, Seoul 110-749, South Korea
bExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
cDepartment of Biology, College of Natural Sciences, Chungnam National University, Taejon 305-764, South Korea
Received 25 February 2002; revised 10 May 2002; accepted 15 May 2002
First published online 5 June 2002
Edited by Veli-Pekka Lehto
Abstract The genetic defect in producing the adipose hormone
leptin results among others in a drastic increase of bone mass.
The current understanding is that under normal circumstances,
osteoblast activity is indirectly suppressed by a hypothalamic
relay induced by leptin-signalling in the brain. To investigate
whether leptin might also regulate osteoblast activity in a direct
manner, expression of leptin receptors in rat osteoblasts was
determined and their functionality was analyzed upon recombi-
nant leptin treatment. Reverse transcription-PCR con¢rmed the
expression of four among the six currently described receptor
isoforms, which were also able to transduce cell signalling as
shown by STAT3 phosphorylation after activation. # 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Identi¢cation of the regulatory mechanism of osteoblast
activity is a key component in understanding the process of
bone formation and remodeling [1]. Recently, a novel path-
way for modulating osteoblast activity has been described [2],
which involves the action of leptin, a small cytokine-like prod-
uct from the ob gene [3]. Leptin is a 16 kDa non-glycosylated
protein, that is produced in adipocytes and which was origi-
nally described to be involved in appetite suppression, energy
expenditure, and body weight regulation [4]. Interestingly, the
recent analysis of naturally occurring leptin- or leptin recep-
tor-de¢cient (OB-R) mice [2] revealed also a signi¢cant in-
crease in bone mass, which reason could be tracked back to
a drastically enhanced osteoblast activity. These ¢ndings con-
sequently lead to the assumption that leptin might be a novel
key regulatory molecule in bone formation.
Further investigations on these mutant mice clearly showed
that under normal conditions leptin indeed suppressed osteo-
blast activity and that this hormone is necessary for the prop-
er control of bone formation and overall bone mass. Never-
theless, its mode of action on osteoblasts is still under dispute.
So far, evidences for both a central regulatory pathway using
the hypothalamic relay [5] as well as for a direct action mech-
anism via endocrine/paracrine pathways [6] have been re-
ported. The failure in detecting leptin receptor expression on
osteoblasts as well as a non-responsiveness to exogenous lep-
tin in these cells were regarded as strong evidences against a
direct regulatory role of leptin in osteoblasts [2], so that this is
currently accepted as the general working model [5]. On the
other hand, there have been also reports on the isolation of
leptin receptor proteins and their activation by leptin in some
mouse osteoblasts, which rather support the possibility of a
direct e¡ect of leptin [6]. To clarify this issue, in the present
study, mRNA were extracted from an established osteoblast
cell line or from primary rat osteoblasts, which have been
isolated in high purity from neonatal rat calvariae, and leptin
receptor expression was determined and con¢rmed by reverse
transcription (RT)-PCR in these cells. This observation was
further con¢rmed by the cell surface staining with leptin re-
ceptor-speci¢c antibodies using immuno£uorescence analysis.
Furthermore, incubation of rat osteoblasts with recombinant
rat leptin resulted in a speci¢c STAT3 (signal transducers and
activators of transcription) phosphorylation in those cells, im-
plicating a direct regulatory role of leptin on osteoblasts.
2. Materials and methods
2.1. Isolation of primary osteoblasts from neonatal rat calvariae
Primary osteoblasts were isolated from the calvariae of 19-day-old
fetal Sprague^Dawley neonate rats by sequential enzymatic digestion
as originally described by Luben et al. [7]. In brief, calvariae were
aseptically dissected, minced and then incubated at 37‡C for 20 min
in a 5.0% CO2 incubator with gentle shaking in an enzymatic solution
containing 0.1% collagenase (Gibco BRL, Grand Island, NY, USA),
0.05% trypsin (Gibco BRL) and 4 mM EDTA (Sigma, St. Louis, MO,
USA) in Hanks’ balanced salt solution (Gibco BRL). This procedure
was repeated ¢ve times. After cells from the ¢rst three digests were
discarded, cells treated for the fourth and ¢fth time under same con-
ditions were collected together and cultured in DMEM media (Gibco
BRL) during the ¢rst 2 days and then changed to BGJb media (Gibco
BRL) supplemented with 10% fetal bovine serum (Gibco BRL), in
which they were maintained for 5 weeks before analysis.
2.2. Isolation of RNA and RT-PCR
Total RNA was isolated using the guanidium^thiocyanate method
as originally described by Chomzynski and Sacchi [8]. In brief, osteo-
blasts were harvested, and the cell pellet was resuspended in an acidic
guanidium^isothiocyanate solution. Protein and DNA fractions were
isolated from the homogenate by acidic phenol (pH 4.0) extraction,
and the upper aqueous phase was transferred into a new reaction tube
to precipitate RNA by addition of 2.5 vol. absolute ethanol. Possible
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contamination of genomic DNA was removed by DNase I treatment.
Puri¢ed total RNA was analyzed in a MOPS-bu¡ered 1.5% agarose
gel containing formaldehyde as denaturing agent. The integrity of the
isolated RNA was then con¢rmed by visualization with EtBr-staining
and UV illumination. For cDNA synthesis, each 1 Wg of the whole
RNA was taken and reverse transcribed in a 40 Wl reaction using
SuperScript1 II reverse transcriptase (Life Technology Inc., Grand
Island, NY, USA) and oligo-dT15 primers (Promega, Madison, WI,
USA) following the protocol as provided by the enzyme supplier. For
the detection of leptin receptor isoform mRNA signals, the following
combination of PCR primers was used (Fig. 1). OB-Ra (5P-aatgaag-
tggcttagaatcc-3P, 5P-tcaaagagtgtccgctctc-3P), OB-Rb (5P-aatgaagtggctt-
agaatcc-3P, 5P-agaccatagctgctggtac-3P), OB-Rc (5P-attgtaccggtaattatttc-
ct-3P, 5P-ctgcaaccttagatatcttgg-3P), OB-Rd (5P-aatgaagtggcttagaatcc-3P,
5P-ctatctgaaaataaaaacttcat-3P), OB-Re (5P-aatgaagtggcttagaatcc-3P, 5P-
gtaaaagcacagtacacatacc-3P), and OB-Rf (5P-aatgaagtggcttagaatcc-3P,
5P-ctaatttctgccaggcatt-3P). The expression of alkaline phosphatase
and osteocalcin was con¢rmed using the following PCR primers:
alkaline phosphatase (5P-tggaatatgaactggatgaga-3P, 5P-gttgttgtgagca-
taatccac-3P), osteocalcin (5P-tctgagtctgacaaagcctt-3P, 5P-ctaaacggtggtg-
ccatagat-3P). For the detection of GAPDH signals, the following
primer pair was used: (5P-caactccctcaagattgtcagc-3P, 5P-gggagttgctgtt-
gaagtcaca-3P). For the detection of rat CD3 and CD11b the following
primer pairs were used, respectively: rat-CD3 (5P-ctgcatccttcaagtgcag-
3P, 5P-catatgcagggcgtcatag-3P), rat-CD11b (5P-cacagtacaccagaactgca-
3P, 5P-atcaccagctggcttagac-3P). PCR was performed using 1 Wl of the
cDNA for 37 cycles under the following conditions: denaturation at
95‡C for 30 s, annealing at 54‡C for 45 s, elongation at 72‡C for 60 s,
and after the last cycle an additional elongation step for 5 min at
72‡C. The RT-PCR products were then loaded in an 1.8% TAE-bu¡-
ered agarose gel and analyzed after gel electrophoresis by EtBr-stain-
ing and UV light illumination.
2.3. Cloning and sequencing of PCR products
Every PCR product as ampli¢ed with the OB-R isotype-speci¢c
primers were cloned into plasmid vectors for determining the identity
of each individual nucleotide sequence. For this, the PCR amplicons
were loaded and separated in an 1.8% TAE-bu¡ered agarose gel, and
then eluted from the gel using the QIAquick gel extraction kit (Qia-
gen, Hilden, Germany) and subcloned into the pGEM-T vector
(Promega). Nucleotide sequencing was performed at the Genome Re-
search Center of the Korea Research Institute of Bioscience and Bio-
technology, Taejon, Korea, using an ABI PRISM DNA sequencing
kit and ABI PRISM 377 DNA sequencer (Perkin Elmer).
2.4. Fluorescence-activated £ow cytometry
Each 4U105 cells were used for one staining reaction. After harvest
from a stationary culture, ROS 17/2.8 cells were stained with either a
commercially available OB-R-speci¢c antiserum (Research Diagnos-
tics Inc., Flanders, NJ, USA) or the same concentration of a control
goat serum in staining bu¡er (0.1% BSA, 0.02% Na-azide in PBS) for
30 min on ice. After washing o¡ excess antibodies with staining bu¡er,
speci¢c binding of the primary antibodies was detected with FITC-
conjugated anti-goat IgG secondary antibodies (DAKO A/S, Glos-
trup, Denmark). Cells were then analyzed in a FACScalibur £ow
cytometer (Becton Dickinson Flow Cytometry Systems, San Jose,
CA, USA).
2.5. STAT3 immunoblot analysis
The detection of leptin-mediated signaling in osteoblasts was per-
formed after treatment of ROS17/2.8 cells and primary osteoblasts
with recombinant rat leptin [9]. STAT3 signaling was analyzed using
a commercial kit (PhosphoPlus Stat3 (Tyr705) Antibody Kit #9130;
New England Biolabs, Beverly, MA, USA) following the manufactur-
er’s instruction. In brief, 1U105 ROS17/2.8 cells/well were seeded into
a 6-well plate and cultured in DMEM (+5%FBS) for 3 days before
analysis. Culture media was then changed into DMEM media without
serum for inducing serum starvation 3 h before leptin treatment. Pu-
ri¢ed recombinant leptin (400 ng/4 ml/well) was then added to the
cells, and after each 0, 3, 10, 15, 30, 60 min incubation, cells were
harvested by lifting the media and by adding 150 Wl SDS sample
bu¡er to scrape the cells o¡ the plate. The cell suspension was then
heated at 100‡C for 7 min, and a 20 Wl aliquot was loaded and
separated in a reducing 12.5% SDS^PAGE. Proteins were then trans-
ferred from the gel by electroblot onto a nitrocellulose membrane
(Amersham-Pharmacia, Uppsala, Sweden), and blocked with 3%
skim milk (Sigma) in PBS at 4‡C overnight under continuous shaking.
Next day, phosphorylated STAT3 was detected using phospho-
STAT3-speci¢c antibodies (Tyr705) diluted 1:1000 in TBS/0.1%
Tween 20 bu¡er by incubation for 2 h at room temperature. Non-
speci¢c binding was washed out with TBS/0.1% Tween 20, and specif-
ically bound antibodies were detected with horseradish peroxidase-
conjugated anti-rabbit immunoglobulin antibodies. The same proce-
dure was applied for detection of STAT3 using STAT3-speci¢c anti-
bodies. Finally, protein bands were visualized by a commercial chemi-
luminescence kit (New England Biolabs). Detection of leptin-mediated
STAT phosphorylation in primary osteoblasts was performed essen-
tially under the same experimental conditions.
3. Results and discussion
To address the central question about leptin receptor ex-
pression in osteoblasts, two di¡erent target cells were used for
analysis. The ROS17/2.8 is an established end-di¡erentiated
osteoblast cell line, which has been extensively characterized
[10] and which has been used in various studies to investigate
the mechanism of bone formation. While this cell line is
clearly the ¢rst choice for analyzing leptin e¡ect on osteo-
blasts, on the other hand, it is also arguable that cell lines
sometimes do not exactly represent the situation in vivo,
which led to the further analysis of also primary osteoblasts
as isolated from neonatal rat calvariae. In contrast to the
ROS17/2.8 cells, primary osteoblasts had to be freshly isolated
for each individual experiment, and isolation processes and
cell culture of these cells are described in details in Section
2. The identity of the isolated osteoblasts was con¢rmed
among others by the speci¢c detection of osteocalcin [11]
and alkaline phosphatase [12] mRNA expression (Fig. 2),
which are classical osteoblast-speci¢c marker genes. Micro-
scopic analysis on the cell morphology also con¢rmed the
identity of the isolated cells (data not shown). After proving
the successful isolation of osteoblasts, RT-PCR was per-
formed to analyze the expression of leptin receptor isoforms
in both ROS17/2.8 and primary osteoblasts, for which six sets
Fig. 1. Schematic presentation of rat leptin receptor isoforms. So
far, six isoforms of the leptin receptor have been reported, which
comprise the OB-Ra, -Rb, -Rc, -Rd, -Re, and -Rf isoforms. Dis-
crimination of the isoform mRNA is possible due to the unique
C-terminal variance between each receptor isotype. The position of
the oligonucleotide primers as used for the speci¢c detection of each
receptor isoforms are indicated in arrows below each receptor iso-
forms. Their sequences are listed in Section 2.
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of primer pairs, corresponding to the six isoforms of rat leptin
receptors, were used. The positions of the primers are shown
in Fig. 1, where all the di¡erentially spliced leptin receptor
(OB-R) isoforms as reported to date are schematically dis-
played.
Fig. 2 shows the result of this experiment. The identities of
the ampli¢ed PCR products were con¢rmed by molecular
cloning and subsequent nucleotide sequencing analysis of
every individual clone upon their correctness (data not shown)
so that the possibility of PCR artifacts could be excluded.
Also a possible contaminating signal from genomic DNA
can be excluded since control PCR with cDNA reactions
without addition of reverse transcriptase showed no speci¢c
signals (data not shown). When using cDNA from primary
osteoblasts (Fig. 2A) for RT-PCR, four among the six re-
ported OB-R isoforms were detected, which are the OB-Ra,
-Rb, -Rc, and the -Rf receptors. No signal for the OB-Rd or
-Re isoforms was detectable in the RT-PCR. Judging from
these results, it can be assumed that four di¡erent isoforms
of leptin receptors are expressed in the osteoblast cells, and,
based on the mRNA signal strength, all four isoforms must be
of a similar expression level whereas the OB-Rf form seems to
be the dominant one. The exact functional role of the OB-Rf
isoforms is still not clear so far. However its detection in
osteoblasts, as shown in this study, is in concordance with
its broad tissue distribution [13] which includes testis, adrenal
gland, and brain, etc.
Interestingly, high-level expression of both the OB-Ra and
-Rb receptors were detected by RT-PCR, which was also ob-
served in ROS17/2.8 rat osteoblast cells (Fig. 2B). Indeed both
cell types showed the same patterns of OB-R isoform expres-
sion, indicating that this expression pro¢le is characteristic for
osteoblast cells. The rather low level of mRNA expression in
ROS17/2.8 cells in comparison to primary osteoblasts might
have been resulted due to repetitive passages of the cell line or
would represent the end-di¡erentiated state of ROS17/2.8
cells. Furthermore, a possible contamination of macrophages
or T-lymphocytes as a source of OB-R mRNA in the pri-
mary osteoblast preparation could not account for the present
observation, since RT-PCR for macrophage-speci¢c genes
(CD11b) or T-cells speci¢c markers (CD3) failed to amplify
speci¢c PCR products (Fig. 2C) from the same RNA prepa-
ration as used in Fig. 2A.
This present observation on OB-Ra and OB-Rb expression
in osteoblasts has a large impact on understanding the bio-
logical mechanism of leptin-mediated modulation of bone
forming activity. Among the six OB-R isoforms, only the
OB-Ra and OB-Rb are able to mediate leptin-induced signal
transduction into the cell [14]. Furthermore, only the OB-Rb
isoform is reported to contain the potential Janus kinase
(JAK) binding domains, box 1 and box 2 (see Fig. 1), and a
potential consensus sequence (YXXQ) for the STAT binding
in its cytoplasmic domain. These characteristics have led to
the assumption that OB-Rb is the major signal-transducing
unit, and all prior analyses on leptin receptor expression in
osteoblasts have been focused on the expression of this recep-
tor isotype [2,6]. Nevertheless, reports on OB-Rb expression
in osteoblast have been contradictory, leading to a dispute
upon either an indirect or direct role of leptin on osteoblasts.
The current observation of signal-transduction capable leptin
receptor (OB-Ra as well as -Rb) expression in osteoblasts thus
implies a direct regulatory role of leptin in bone morphogen-
esis and this is also in accordance to a recent study by Step-
pan et al. [6], who were able to detect OB-Rb expression in
mouse osteoblasts. The reason why others [2] were not able to
detect OB-Rb expression in primary osteoblasts remains elu-
sive. However regarding the fact that tissue-speci¢c expression
of OB-Rb has been disputed also in other organs, it might be
assumed that detection of OB-Rb expression is largely depen-
dent on the experimental procedure.
Indeed, there have been also some controversies regarding
the presence of OB-Rb, for example in the kidney, where
some investigators could [15] or could not [16] detect OB-
Rb expression. Also, both the absence and presence of OB-
Rb expression in muscle tissues have been reported by di¡er-
ent groups [15^17] as well as are there controversies in other
tissues including the adrenal gland, spleen, etc. It has been
proposed that the reason for such inconsistencies might be
due to a sensitivity problem of the applied detection methods
or either due to di¡erential physical or nutritional state of the
laboratory animals. In the latter case, di¡erent conditions
might directly a¡ect the serum leptin level and this in turn
would modulate leptin receptor level resulting in the di¡er-
ences of the read-out.
The next question in the present study regarded whether
leptin receptor mRNA products as detected by RT-PCR are
indeed expressed and transported to the cell surface. To ad-
dress this issue, indirect immuno£uorescence analysis was per-
formed on osteoblasts cells using leptin receptor-speci¢c anti-
bodies, which are directed to the 32^51 amino acid region at
the amino terminus of the mouse leptin receptor. This com-
mercially available antibody (Research Diagnostic Inc.) has
been proved on prior occasions to speci¢cally interact also
rat leptin receptors ([18] and communication from manufac-
turer). Fig. 3 shows the result from £ow cytometric analysis,
where ROS17/2.8 cells were ¢rst stained with these leptin re-
ceptor-speci¢c antibodies and then the speci¢c stainings were
visualized by £uorescence (FITC)-conjugated anti-goat immu-
Fig. 2. Determination of leptin receptor isoform expression in pri-
mary rat osteoblasts. Using OB-R isoform-speci¢c primers, the ex-
pressions of leptin receptor isoforms were determined in (A) primary
rat osteoblasts, or (B) in the rat osteoblast cell line ROS 17/2.8 us-
ing RT-PCR. a, OB-Ra; b, OB-Rb; c, OB-Rc; d, OB-Rd; e, OB-
Re; f, OB-Rf; 1, GAPDH; 2, alkaline phosphatase; 3, osteocalcin.
C: To con¢rm the purity of the isolated primary osteoblasts, RT-
PCR was performed with either primary osteoblasts RNA or rat
whole spleen RNA. M, molecular weight marker lane; 1, GAPDH;
2, CD3; 3, CD11b.
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noglobulin secondary antibodies. Here it is to see that the log
£uorescence of osteoblasts stained with the anti-leptin recep-
tor antibodies (open histogram) drastically shifts to the right
in the x-axis indicating a high and speci¢c staining of the cells
by this antibody. On the other hand, the same osteoblasts
stained with a control goat antibody (speci¢c for an irrelevant
human immunode¢ciency virus envelope protein) showed no
increased £uorescence signals (¢lled histogram). Upon con¢r-
mation of the cell surface expression of leptin receptors, the
leading question was whether they would be also functional
for leptin-mediated signal transduction. It is currently ac-
cepted that ligand-binding to the leptin receptor induces the
expression of several genes including the socs-3 (suppressor-
of-cytokine-signaling), and c-fos as well as activates some oth-
er intracellular signaling components such as STAT, phospha-
tidylinositol 3-kinase [19] and MAPK (ERK) activity [20]. The
determination of induction of either such target genes or ac-
tivation of downstream signaling pathways would be a good
proof for the activity of ligand-bound leptin receptors. In this
regard, the current study focused on a possible activation of
down-stream components in the leptin receptor signaling,
which would prove the functionality of these receptors.
Speci¢c phosphorylation of STAT proved to be the most
direct and a⁄rmative way in detecting leptin receptor signal-
ing [14]. However, while several di¡erent STAT isoforms have
been reported to be activated by leptin, so far only STAT3
has been proved to be active after leptin-mediated signaling in
the hypothalamus, the major action site of leptin. This then
lead to the suggestion that STAT3 might be the most crucial
component in leptin receptor signaling [20], and that detection
of STAT3 phosphorylation would serve as the conclusive
proof for the direct leptin activity in osteoblasts as aimed in
the current study. For activating ROS17/2.8 rat osteoblasts,
recombinant rat leptin was used which had been expressed in
E. coli [9], and which biological activity had been previously
con¢rmed by an in vitro assay. Since leptin receptor-trans-
fected cells showed a saturation of leptin-mediated signaling
after a concentration of 20 ng/ml using this recombinant pro-
tein [18], in the present study, osteoblasts were stimulated with
leptin to a ¢nal concentration of 100 ng/ml to ensure a suc-
cessful binding of leptin to their cognate receptors. As shown
in Fig. 4A, leptin treatment indeed initiated a strictly time-
dependent phosphorylation of STAT3 indicating that the
JAK-mediated signaling to STAT3 activation was intact and
functional. While no densitometric analysis of the signal in-
tensity has been performed, it is clear to see that STAT3
phosphorylation is induced by leptin treatment and that this
signal peaks after 30 min. Cross-reactivity of bovine leptin
derived from culture media serum can be largely excluded
since the cells have been prior starved under serum-devoid
conditions, and since cells without exogenous leptin treatment
showed no increase in phospho-STAT3 signals. The same ob-
servation was con¢rmed when using primary osteoblasts
(Fig. 4B), where the incubation with leptin also induced
STAT3 phosphorylation with a similar kinetic as ROS17/2.8
cells. Thus, it is concluded that both osteoblast cell lines as
well as primary osteoblasts are able to respond to exogenous
leptin, and that there are indeed signal transduction-capable
receptors for leptin are expressed on those cells.
After determining the leptin-mediated signal transduction in
osteoblasts, it is now of course of great interest, which genes
would be down-stream to the STAT3 signal in these cells. It is
our belief that such information will provide further clues on
Fig. 4. Determination of leptin-mediated cell signaling in ROS 17/2.8 cells and primary osteoblasts. Analysis of STAT3 phosphorylation in lep-
tin stimulated rat osteoblasts. A: Recombinant leptin-treated ROS 17/2.8 cells were harvested in a time-dependent manner, and the cell lysate
was probed in an immunoblot with either STAT3 or phosphorylated STAT3-speci¢c antibodies. B: Same experiment was performed with pri-
mary osteoblasts which have been cultured for 2 weeks after isolation from neonatal rat calvariae.
Fig. 3. Flow cytometric analysis of OB-R expression in rat osteo-
blasts. Using commercially available leptin receptor-speci¢c antibod-
ies, the cell surface expression of leptin receptor in ROS 17/2.8 os-
teoblasts was analyzed. The FACS analysis data is a representative
result from ¢ve independently performed experiments. Indirect im-
muno£uorescence with FITC-conjugated rabbit anti-goat antibodies
as secondary antibodies enabled the detection of speci¢cally bound
primary antibodies. Open histogram indicates the distribution of the
relative £uorescence intensity of anti-OB-R staining, while ¢lled his-
togram shows the staining with a control antibody.
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the actual role of leptin in bone remodeling as well as is it
expected to help the further identi¢cation of genes directly
involved in this process, which will be the subject of our
next studies.
In conclusion, the current study shows the physical presence
and cell surface expression of leptin receptors in osteoblasts
and thereby suggests a direct regulatory role of leptin in the
bone formation processes. Furthermore, the phosphorylation
of STAT3 by leptin treatment indicated that the expressed
leptin receptors are functionally active and that they success-
fully mediate signal transduction into the cytoplasm. While
the possibility of an alternative mechanism of a central endo-
crine or neuroendocrine pathway using a hypothalamic relay
can not be excluded [2,6], it is evident that the current study
rather supports the postulation on a direct e¡ect of leptin on
bone growth as also suggested by others [6,21].
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